MelliCell, Inc.

🎉 As We Step Into 2025, Thank You for Believing in Us! 🎉 2024 has been a year of milestones, challenges, and breakthroughs at MelliCell. None of it would have been possible without the dedication of our incredible team and the unwavering support of our collaborators. 💡 To our team: Your hard work and commitment have been nothing short of extraordinary. From refining the M3 platform to uncovering critical insights into chronic and metabolic diseases, you’ve taken on every challenge and turned it into progress. Thank you for your passion, persistence, and belief in what we’re building together. 👏 To our supporters: Your trust and collaboration have meant the world to us. Whether through partnerships, funding, or simply cheering us on, you’ve been a cornerstone of our journey. Your feedback has sharpened our focus and fueled our mission to make a real impact on healthcare. 🌟 This year reminded us that progress is never achieved alone—it’s built together. As we step into 2025, we’re excited to continue this journey with all of you, working toward a healthier future for everyone. To the dreamers, the doers, and everyone who believes in making a difference—thank you for being part of our story. #HappyNewYear #MelliCell #ChronicDisease #MetabolicDisease #Fatcell #Gratitude #Teamwork #Collaboration

Check out our feature at the 1st Annual BioPharma Obesity Innovation Forum! Fat cells: often misunderstood, rarely celebrated. At MelliCell, we see them differently—as a powerful key to tackling obesity and chronic diseases. With our cutting-edge technology and unstoppable team, we’re turning adipocytes into allies. Exciting progress is underway, and the future of health is looking leaner and brighter! #obesity #aging #chronicdisease #diabetes

Happy Thanksgiving from All of Us at MelliCell! This Thanksgiving, we’re pausing (briefly) from growing adipocytes and chasing breakthroughs to reflect on what truly matters: Our Incredible Team – Your brilliance, dedication, and occasional science puns keep our mission alive. Together, we’re not just developing therapies—we’re building a better future. Our Supporters – Whether you’re cheering from the sidelines, believing in our research, or helping us dream big, you’re the fuel behind our progress. We couldn’t do this without you! The Journey – Science has its ups, downs, and “what just happened?” moments, but we’re grateful for every step as we push the boundaries of what’s possible in metabolic health. From all of us at MelliCell, we wish you a day filled with gratitude, connection, and maybe a slice (or two) of pie. Here’s to a future full of health, innovation, and continued collaboration. #HappyThanksgiving #Gratitude

Today, we honor the courage, dedication, and sacrifice of our veterans. Their commitment to service inspires us to push forward in our mission to improve health and well-being. Thank you to all veterans for your bravery and the sacrifices you’ve made for our freedom. #VeteransDay #ThankYouVeterans ##HonorOurHeroes

Exciting News! 🎉 We are thrilled to announce that MelliCell, Inc. has been awarded a NIH/NIDDK SEED grant in partnership with Mass General Brigham! This achievement reflects the collective efforts of our incredible team, and we'd like to extend special recognition to: Ben Pope – CEO, Mellicell Madhumita Basu – Principal Scientist, Target Discovery, Mellicell Luminita Pojoga – Associate Director, HMCI Lab, Mass General Brigham Thank you to everyone involved—your hard work and dedication made this milestone possible! With our M3 platform, we are unlocking the potential of fat cells to drive new therapies for diabetes, obesity and other metabolic diseases. Learn more: https://lnkd.in/e7b7yzzw #Fatcell #metabolicdiseasetherapy #NIH #NIDDK #MGH #Obesity #Diabetes

Check out this insightful interview with Dr. Prince Nnah, by Propel Labs! 🎥 In the interview, Prince discusses his vision for healthcare innovation and the groundbreaking work Team Mellicell is doing to tackle obesity, diabetes, and other metabolic diseases using our proprietary M3 technology. Watch the full interview here: https://lnkd.in/drdE3pqZ #HealthcareInnovation #Biotech #fatcells #Obesity #Diabetes #Metabolicdiseases #MelliCell

🎆 Happy Independence Day! 🎆 Today, we reflect on the 4th of July, celebrating freedom, courage, and unity. We honor the sacrifices of those who fought for our independence and the enduring spirit of innovation that shapes America. At Mellicell, we are inspired by these values as we strive to combat diabesity and improve lives. We are proud to be part of a nation where dreams are possible and innovation thrives. Wishing you and your loved ones a joyous and reflective 4th of July! 🇺🇸 #IndependenceDay #4thOfJuly #HealthcareInnovation #DiabesityAwareness #Obesity #Diabetes #Biotech

Dr. Fatima Coddy Stanford raises crucial safety concerns about counterfeit and compounded GLP-1 agents for obesity in her recent interview with WCVB-TV Channel 5 in Boston. These untested and unvalidated drugs pose serious health risks. It's essential to prioritize safety and use only FDA-approved treatments. Thank you, Jenny Barron, for your investigative work on this critical issue. #Obesity #GLP1 #Safety #Health https://lnkd.in/eSJYy_WN

Honoring Freedom and Resilience: Happy Juneteenth! Today, we honor Juneteenth, a day that symbolizes freedom and resilience. At Mellicell Inc., we stand in solidarity with the African American community, celebrating their strength and contributions. As we work towards better health solutions, we’re reminded of the importance of equality in every aspect of life. Let’s continue to push for justice and inclusivity together. Happy Juneteenth! #Juneteenth #Equality #Inclusion #Mellicell

🇺🇸 To all who served, thank you! 🇺🇸 Your courage and dedication inspire us every day at MelliCell as we strive to improve health outcomes for all. We honor your sacrifices and commitment. #MemorialDay #HonorAndRemember #MelliCell #Diabetes #Obesity #Biotech #HealthcareInnovation #DiabetesResearch #ObesityTreatment #Veterans #NeverForget